Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN4A | P35499 | 1/20 | 0.39 |
| ▸ | PRCP | P42785 | 2/20 | 0.38 |
| ▸ | GLI1 | P08151 | 1/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4153806 | 0.81 | SCN4A (0.42) | SCN4APRCPGLI1DPP7FDPS | |
| SCHEMBL7746794 | 0.78 | SCN4A (0.40) | SCN4APRCPGLI1DPP7NOS2 | |
| SCHEMBL3632516 | 0.75 | SCN4A (0.46) | SCN4APRCPGLI1DPP7NOS2 | |
| SCHEMBL5048080 | 0.75 | SCN4A (0.46) | SCN4APRCPGLI1DPP7NOS2 | |
| SCHEMBL2917600 | 0.74 | GLI1 (0.58) | SCN4APRCPGLI1DPP7FDPS | |
| SCHEMBL10067946 | 0.74 | PRCP (0.44) | SCN4APRCPDPP7HTR2CHTR2B | |
| SCHEMBL3832254 | 0.74 | GLI1 (0.58) | SCN4APRCPGLI1DPP7FDPS | |
| SCHEMBL8285912 | 0.74 | PRCP (0.44) | SCN4APRCPDPP7HTR2CHTR2B | |
| SCHEMBL10067945 | 0.74 | PRCP (0.44) | SCN4APRCPDPP7HTR2CHTR2B | |
| SCHEMBL16992331 | 0.74 | GLI1 (0.58) | SCN4APRCPGLI1DPP7FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063701-A1 | Piperidine derivatives and anti-platelet agents containing the same | AJINOMOTO CO., INC (JP) | 2004-04-01 | — | — | US | claimed |
| US-20020147195-A1 | Piperidine derivatives and anti-platelet agents containing the same | AJINOMOTO CO., INC. (JP) | 2002-10-10 | — | — | US | claimed |
| US-20020019533-A1 | PIPERIDINE DERIVATIVES AND ANTI-PLATELET AGENTS CONTAINING THE SAME | MAKINO SHINGO (JP) | 2002-02-14 | — | — | US | claimed |
| EP-0682015-B1 | Piperidine derivates and anti-platelet agents containing the same | AJINOMOTO KK (JP) | 2001-08-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019533-A1 | PIPERIDINE DERIVATIVES AND ANTI-PLATELET AGENTS CONTAINING THE SAME | HTR2A, PDGFRA, PDGFRB | SCN4A 2069/4885PRCP 1438/4885GLI1 3203/4885 |
| US-20020147195-A1 | Piperidine derivatives and anti-platelet agents containing the same | HTR2A, PDGFRA, PDGFRB | SCN4A 2069/4885PRCP 1438/4885GLI1 3203/4885 |
| US-20040063701-A1 | Piperidine derivatives and anti-platelet agents containing the same | HTR2A, PDGFRA, PDGFRB | SCN4A 2069/4885PRCP 1438/4885GLI1 3203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.